in this issue
People & Business :: Companies
Bayer Sues Teva for Patent Infringement
8:29 AM MDT | July 6, 2009 | Natasha Alperowicz
Bayer Schering Pharma AG, Bayer HealthCare Pharmaceuticals Inc., and Schering Corporation have jointly filed a patent infringement lawsuit in the U.S. Federal Court in the District of Delaware against Teva Pharmaceuticals USA and Teva Pharmaceutical Industries Ltd. The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Levitra, Bayer Schering Pharma's therapy for the treatment of erectile dysfunction, prior to patent expiration. Bayer says the patent at issue is Bayer Schering Pharma's U.S. Patent No. 6,362,178...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee